Florent Beaufils
8Patents
2h-index
19Co-inventors
40Inventor score
Filing activity: Oct 3, 2014 → Mar 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9556203B2 | Conformationally restricted P13K and mTOR inhibitors | Chemistry; Metallurgy | 7 | Active |
| US10640516B2 | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | Chemistry; Metallurgy | 3 | Active |
| US11186591B2 | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | Chemistry; Metallurgy | 2 | Active |
| US10993947B2 | Treatment of skin lesions | Human Necessities | 1 | Active |
| US11878972B2 | Treatment of neurological disorders | Chemistry; Metallurgy | 0 | Active |
| US10100031B2 | Manufacturing process for triazine, pyrimidine and pyridine derivatives | Chemistry; Metallurgy | 0 | Active |
| US11918586B2 | Treatment of skin lesions | Human Necessities | 0 | Active |
| US10766874B2 | Manufacturing process for triazine, pyrimidine and pyridine derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.